Pegfilgrastim is a type of oncology drug used to treat neutropenia, a condition in which the body does not produce enough white blood cells. It is a long-acting form of filgrastim, a recombinant human granulocyte colony-stimulating factor (G-CSF) that stimulates the production of neutrophils, a type of white blood cell. Pegfilgrastim is used to reduce the duration and severity of neutropenia and the associated risk of infection in patients receiving chemotherapy for certain types of cancer. It is also used to reduce the duration of neutropenia and the associated risk of infection in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs. Pegfilgrastim is available in both brand-name and generic forms. It is marketed by several pharmaceutical companies, including Amgen, Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
